ARCHIVES

FDA Committee Approves NDA for Mitxantrone

This article is from The Cancer Letter archive.

Vol. 12 No. 12 | March 21, 1986

Download PDF Visit The Full Archive

Related Articles

Report Urges Changes To Cut Activation Times For NCI Phase III Trials.

April 9, 2010

Working Group Nears Agreement On New Core Grant Guidelines

January 16, 1981

Screening Frequency for Cervical Cancer May Be Reduced, ACS Says

November 22, 2002

Small Business Technology Transfer Program Solicitation

June 23, 1995

Advisers Fume Over Preventions Budget Cut; NIH Probably Did It

May 22, 1992

In Brief; NCAB Goes Along With NCI Staff In Funding EORTC Statistical Center Grant Out Of Priority Sequence

November 20, 1981